Comparison of the Efficacy and Safety of 2 Oral Doses of Rimonabant, 5 mg/Day or 20 mg/Day, Versus Placebo, as an Aid to Smoking Cessation (STRATUS US)
Clinical trial NCT00358228 · COMPLETED
Trial details
- NCT number
- NCT00358228
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-09-01
- Primary completion
- 2003-08-01
- Enrollment
- 787
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.